Risk Evaluation and Mitigation Strategies (REMS)
and Opioid Analgesics Webinar
The Center for Drug Evaluation and Research (CDER) and Office of Special Health
Issues (OSHI) developed the following Webinar to better inform stakeholders about general issues related to Risk Evaluation and Mitigation Strategies (REMS) and specific issues related to REMS for certain opioid analgesics.
Part I –Introduction (8:21 minutes)
Douglas C. Throckmorton, M.D.
Deputy Director (CDER)
https://webmeeting.nih.gov/p53364025/
Part II – Opioid Analgesics (6:28 minutes)
Sharon Hertz, M.D., Deputy Division Director
Division of Anesthesia, Analgesia, and Rheumatology Products (CDER)
https://webmeeting.nih.gov/p59178873/
Part III – REMS (23:51 minutes)
John Jenkins, M.D.
Director, Office of New Drugs (CDER)
https://webmeeting.nih.gov/p51598115/
Part IV – Next Steps (6:22 minutes)
John Jenkins, M.D.
Director, Office of New Drugs (CDER)
https://webmeeting.nih.gov/p57998755/
PDF Version of Slides
Back
to Top Back to Opioids
PDF requires the free Adobe Acrobat Reader
Date created: April 27, 2009 |